Chernett Jorey 4

What Happened

• Jorey Chernett, a reported 10% beneficial owner of Neuronetics, purchased a total of 200,000 shares in two open-market transactions: 100,000 shares on 2026-04-20 and 100,000 shares on 2026-04-21. The filings report weighted-average prices of $1.58 (≈ $158,000) and $1.51 (≈ $151,000), for a combined outlay of roughly $309,000. These were purchases, which some investors view as a bullish signal (but note this is factual reporting, not commentary on motive).

Key Details

• Transaction dates and prices:
  • 2026-04-20: Purchase (P) — 100,000 shares at weighted avg $1.58 (transactions ranged $1.56–$1.59). Total ≈ $158,000. (Footnote F1)
  • 2026-04-21: Purchase (P) — 100,000 shares at weighted avg $1.51 (transactions ranged $1.50–$1.52). Total ≈ $151,000. (Footnote F2)
• Shares owned after transaction: Not specified in the Form 4 filing provided.
• Footnotes: Each reported price is a weighted average; Mr. Chernett states he will provide detailed per-transaction pricing to the issuer, any security holder, or the SEC staff upon request.
• Filing timeliness: Form 4 was filed on 2026-04-22 for transactions on 4/20 and 4/21 — within the typical 2-business-day reporting window (timely).

Context

• As a 10% owner, Chernett is a large beneficial holder rather than necessarily an executive; purchases by large holders can reflect investment decisions but do not by themselves indicate company operational insight.
• These were straightforward open-market purchases (code P). No options exercised, awards, gifts, or tax-withholding events were reported in this filing.